Thiruvananthapuram | SCTIMST on Thursday said it has fabricated what it claims is the "world's first tissue graft scaffold" ...

BioStem said the acquisition will support its advancement into ‘high value’ adjacent market segments.

Galderma to showcase the latest scientific advances behind the industry’s broadest injectable aesthetics portfolio at IMCAS 2026: Zug, Switzerland Friday, January 23, 2026, 12:0 ...

Osteocytes, the most abundant cells in bone tissue, have long been underestimated in their functional capacity. Traditionally viewed as passive entities, recent research has illuminated their pivotal ...

Aroa Biosurgery has strengthened the case for its Myriad bioscaffolds with new data from an ongoing study demonstrating ...

Sanara MedTech Inc. ("Sanara MedTech," "Sanara," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing ...

Stanford researchers develop a therapy that regenerates cartilage and blocks osteoarthritis in ageing joints, showing promise for future treatments that restore joint health Stanford researchers have ...

Biofilm research sits at the intersection of microbiology, infectious diseases, and biotechnology, addressing the complex multicellular communities that ...

Researchers from Johns Hopkins Medicine, utilizing mouse models, reveal that oligodendrocyte precursor cells differentiate at a consistent, extensive rate throughout adulthood.

Prostaglandin analogues, such as latanoprost and bimatoprost, are the go-to therapies for glaucoma therapy. They continue to ...

Detailed price information for Sanara Medtech Inc (SMTI-Q) from The Globe and Mail including charting and trades.